Browse the latest research summaries in the field of pharmacology for spinal cord injury patients and caregivers.
Showing 311-320 of 639 results
PLoS ONE, 2021 • February 24, 2021
This study demonstrates that SCI accelerates the rate of AD in the aortic arch in a mouse model of AD. Treatment of SCI mice with Salsalate for 4 weeks after injury resulted in a significant decrease ...
KEY FINDING: Spinal cord injury accelerates aortic atherosclerotic disease and associated risk factors in ApoE-/- mice.
Molecular Pain, 2021 • February 4, 2021
This study investigates the potential of electroacupuncture (EA) to alleviate neuropathic pain by suppressing P2X7R expression in a rat model of spinal nerve ligation (SNL). The research aims to under...
KEY FINDING: EA treatment increased pain threshold in SNL rats, indicating pain relief, while the P2X7R agonist BzATP suppressed this EA-induced increase.
Frontiers in Pharmacology, 2021 • February 8, 2021
This study observed that CTP improved functional recovery, reduced the neuronal apoptosis, inhibited inflammation and oxidative stress in SCI mice. miR-142 was up-regulated by CTP, and inhibition of mi...
KEY FINDING: CTP treatment could improve the functional recovery, as well as suppress the apoptosis, alleviate inflammatory and oxidative response in SCI mice.
Scientific Reports, 2021 • April 8, 2021
This study investigated the effect of early escitalopram administration on spasticity after contusive spinal cord injury (SCI) in rats. Escitalopram, a selective serotonin re-uptake inhibitor (SSRI), ...
KEY FINDING: Early escitalopram administration suppressed spastic behaviors during the swimming test in rats with contusive SCI.
Journal of Clinical Medicine, 2021 • March 8, 2021
This pilot study investigated the efficacy and safety of adding transdermal neostigmine and glycopyrrolate, delivered via iontophoresis, to the standard bowel care (SOC) regimen for individuals with s...
KEY FINDING: The addition of transdermal neostigmine and glycopyrrolate significantly reduced the time to bowel evacuation compared to standard of care alone.
J Med Case Reports, 2021 • May 12, 2021
This case report presents a rare instance of a gabapentin-induced coma in a patient with spinal cord injury, successfully reversed by flumazenil. The patient, a 70-year-old man with tetraplegia, exper...
KEY FINDING: A 70-year-old man with tetraplegia developed a coma after gabapentin administration, despite normal renal and liver function.
Toxins, 2021 • May 22, 2021
This review provides a comprehensive overview of lanbotulinumtoxinA (LAN) research, compiling a complete English bibliography and analyzing publications until July 1, 2018. The study categorizes LAN a...
KEY FINDING: A total of 379 LAN publications were identified, with the majority published in Chinese. The review categorizes these publications based on indications, including motor, glandular, pain, and aesthetic uses.
Neurotrauma Reports, 2021 • January 1, 2021
This study evaluated the adverse effects of high-dose methylprednisolone (MP) administration on bone loss after acute spinal cord injury (SCI) in rats. The results showed that MP significantly reduced...
KEY FINDING: High-dose MP administration significantly reduced bone mineral density (BMD) in the distal femur and proximal tibia of SCI rats compared to SCI-vehicle animals.
Medicine, 2022 • October 7, 2022
This study used network pharmacology and molecular docking to investigate the mechanism of Buyang Huanwu Decoction (BYHWD) in treating spinal cord injury (SCI). The study identified key active compoun...
KEY FINDING: The study identified 109 active compounds and 5440 prediction targets from Buyang Huanwu Decoction, with 98 active components and 49 related prediction targets being strongly linked to Spinal Cord Injury.
Evidence-Based Complementary and Alternative Medicine, 2022 • October 7, 2022
This study investigates the analgesic effects of electroacupuncture (EA) on neuropathic pain in a chronic constriction injury (CCI) rat model. The research focuses on the role of GABAA receptors and m...
KEY FINDING: EA treatment relieves mechanical allodynia and thermal hyperalgesia in CCI rats, as demonstrated by increased MWT and TWL values compared to the CCI group.